urge urinary incontinence. Other specified urinary incontinence
Conditions
Interventions
Intervention 1: Intervention group: Traditional Herbal Syrup which is a aqueous extract of "Myrtus Communis" leaves.
Dosage: 15 cc 20-40 min after each meal means 45 cc per day. Intervention 2: Contro
Treatment - Drugs
Intervention group: Traditional Herbal Syrup which is a aqueous extract of "Myrtus Communis" leaves.
Dosage: 15 cc 20-40 min after each meal means 45 cc per day.
Control group: Tab 2 mg "Toltrodine" 2 times a day.
Sponsors
Vice Chancellor for Research, Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Female with urge incontinence or mixed incontinence with urge dominance; Who have been symptomatic from at least 3 months ago; Not have been treated for at least 2 week; and are health mentally. Exclusion criteria: Positive urine culture; Uncontrolled diabetic; Uncontrolled HTN; History of glaucoma; History of drug allergy; Neuralgic disease; Bladder cancer; Hematuria; Residual volume more than 110 in sonography; Any voiding dysfunction in history
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of the symptoms severity. Timepoint: Before and 4 weeks after treatment. Method of measurement: ICIQ-SF questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Advers effect of drug. Timepoint: any time after starting drug. Method of measurement: asking from patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Nojavan
Research Institute for Islamic and Complementary Medicine
Outcome results
None listed